These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 32202687)

  • 21. Stability Studies on Dry Swabs and Wet Mailed Swabs for Detection of Chlamydia trachomatis and Neisseria gonorrhoeae in Aptima Assays.
    Moncada J; Clark CB; Holden J; Hook EW; Gaydos CA; Schachter J
    J Clin Microbiol; 2017 Mar; 55(3):971-977. PubMed ID: 28077695
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Time to clearance of Chlamydia trachomatis RNA and DNA after treatment in patients coinfected with Neisseria gonorrhoeae - a prospective cohort study.
    Wind CM; Schim van der Loeff MF; Unemo M; Schuurman R; van Dam AP; de Vries HJ
    BMC Infect Dis; 2016 Oct; 16(1):554. PubMed ID: 27724878
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of the Gen-Probe APTIMA Combo 2 assay to the AMPLICOR CT/NG assay for detection of Chlamydia trachomatis and Neisseria gonorrhoeae in urine samples from Australian men and women.
    Lowe P; O'Loughlin P; Evans K; White M; Bartley PB; Vohra R
    J Clin Microbiol; 2006 Jul; 44(7):2619-21. PubMed ID: 16825397
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The diagnostic-escape Finnish new variant of Chlamydia trachomatis first described in 2019 remains present in Finland three years after the introduction of an updated Aptima Combo 2 assay.
    Puolakkainen M; Mannonen L; Unemo M
    Clin Microbiol Infect; 2023 May; 29(5):658-659. PubMed ID: 36804908
    [No Abstract]   [Full Text] [Related]  

  • 25. Detection of Chlamydia trachomatis and Neisseria gonorrhoeae infections in North American women by testing SurePath liquid-based Pap specimens in APTIMA assays.
    Chernesky M; Freund GG; Hook E; Leone P; D'Ascoli P; Martens M
    J Clin Microbiol; 2007 Aug; 45(8):2434-8. PubMed ID: 17581931
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of urine testing in evaluations of the sensitivity of the Gen-Probe Aptima Combo 2 assay on endocervical swabs for Chlamydia trachomatis and neisseria gonorrhoeae: the infected patient standard reduces sensitivity of single site evaluation.
    Moncada J; Schachter J; Hook EW; Ferrero D; Gaydos C; Quinn TC; Willis D; Weissfeld A; Martin DH
    Sex Transm Dis; 2004 May; 31(5):273-7. PubMed ID: 15107628
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High-volume workflow and performance comparisons for Chlamydia trachomatis and Neisseria gonorrhoeae testing using automated molecular platforms.
    Frontzek A; Aretzweiler G; Winkens D; Duncan D; Marlowe EM
    BMC Infect Dis; 2019 Sep; 19(1):797. PubMed ID: 31510949
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multicenter study of nucleic acid amplification tests for detection of Chlamydia trachomatis and Neisseria gonorrhoeae in children being evaluated for sexual abuse.
    Black CM; Driebe EM; Howard LA; Fajman NN; Sawyer MK; Girardet RG; Sautter RL; Greenwald E; Beck-Sague CM; Unger ER; Igietseme JU; Hammerschlag MR
    Pediatr Infect Dis J; 2009 Jul; 28(7):608-13. PubMed ID: 19451856
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of the Roche cobas® CT/NG test for detection of Chlamydia trachomatis and Neisseria gonorrhoeae in male urine.
    Taylor SN; Liesenfeld O; Lillis RA; Body BA; Nye M; Williams J; Eisenhut C; Hook EW; Van Der Pol B
    Sex Transm Dis; 2012 Jul; 39(7):543-9. PubMed ID: 22706217
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Validation of the APTIMA Combo 2 assay for the detection of Chlamydia trachomatis and Neisseria gonorrhoeae in SurePath liquid-based pap test samples taken with different collection devices.
    Chernesky M; Jang D; Smieja M; Portillo E; Ewert R; Pritchard C; MacEachern D; Doucette C; MacDonald A; Kapala J; Sumner J; Hill C
    Sex Transm Dis; 2009 Sep; 36(9):581-3. PubMed ID: 19661842
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of three assays for detection of Chlamydia trachomatis and Neisseria gonorrhoeae in SurePath Pap samples and the role of pre- and postcytology testing.
    Chernesky M; Jang D; Portillo E; Smieja M; Kapala J; Doucette C; Sumner J; Ewert R; MacRitchie C; Gilchrist J
    J Clin Microbiol; 2012 Apr; 50(4):1281-4. PubMed ID: 22259215
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The verification of nucleic acid amplification testing (Gen-Probe Aptima Assay) for chlamydia trachomatis from ocular samples.
    Kowalski RP; Karenchak LM; Raju LV; Ismail N
    Ophthalmology; 2015 Feb; 122(2):244-7. PubMed ID: 25439605
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular genetic methods for diagnosis and characterisation of Chlamydia trachomatis and Neisseria gonorrhoeae: impact on epidemiological surveillance and interventions.
    Fredlund H; Falk L; Jurstrand M; Unemo M
    APMIS; 2004; 112(11-12):771-84. PubMed ID: 15638837
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gonococcal NAATs: what is the current state of play in England and Wales?
    Benzie A; Alexander S; Gill N; Greene L; Thomas S; Ison C
    Int J STD AIDS; 2010 Apr; 21(4):246-8. PubMed ID: 20378894
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Abilities of APTIMA, AMPLICOR, and ProbeTec assays to detect Chlamydia trachomatis and Neisseria gonorrhoeae in PreservCyt ThinPrep Liquid-based Pap samples.
    Chernesky M; Jang D; Portillo E; Chong S; Smieja M; Luinstra K; Petrich A; Macritchie C; Ewert R; Hayhoe B; Sarabia A; Thompson F
    J Clin Microbiol; 2007 Aug; 45(8):2355-8. PubMed ID: 17537943
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of the Abbott RealTime CT new formulation assay with two other commercial assays for detection of wild-type and new variant strains of Chlamydia trachomatis.
    Møller JK; Pedersen LN; Persson K
    J Clin Microbiol; 2010 Feb; 48(2):440-3. PubMed ID: 20007394
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Performance of strand displacement amplification assay in the detection of Chlamydia trachomatis and Neisseria gonorrhoeae.
    Fontana C; Favaro M; Cicchetti O; Minelli S; Pistoia ES; Favalli C
    Jpn J Infect Dis; 2005 Oct; 58(5):283-8. PubMed ID: 16249622
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of the new COBAS TaqMan CT test v2.0 and impact on the proportion of new variant Chlamydia trachomatis by the introduction of diagnostics detecting new variant C trachomatis in Orebro county, Sweden.
    Hadad R; Fredlund H; Unemo M
    Sex Transm Infect; 2009 Jun; 85(3):190-3. PubMed ID: 19060034
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Detection of Chlamydia trachomatis and Neisseria gonorrhoeae based on cross-priming amplification.
    Yu B; An Y; Xu G; Shan H
    Lett Appl Microbiol; 2016 May; 62(5):399-403. PubMed ID: 26949934
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of nucleic acid amplification testing for diagnosis of anorectal sexually transmitted infections.
    Cosentino LA; Campbell T; Jett A; Macio I; Zamborsky T; Cranston RD; Hillier SL
    J Clin Microbiol; 2012 Jun; 50(6):2005-8. PubMed ID: 22493338
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.